Financials

  • Market Capitalization 93.48 M
  • Employee 12
  • Founded 2023
  • CEO N/A
  • Website www.retensionpharmaceuticals.com
  • Headquarter Delaware, United States
  • FIGI BBG01PDS76B4
  • Industry N/A

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4151
GLAS
Glass House Brands Inc.
1.1750 USD-2.49%-6.75%-48.46%-90.63%94.04 M USD
4152
RACD
Research Alliance Corporation IV Class A Ordinary Shares
10.3200 USD0.00%-0.39%-2.18%-0.29%93.90 M USD
4163
ZSQR
Z Squared Inc. Common Stock
1.74 USD-5.43%-26.58%-50.99%-90.74%92.22 M USD
4168
JTTT
JATT III Acquisition Corp Ordinary Shares
10.30 USD0.00%+0.19%-0.19%-6.36%91.25 M USD

Frequently asked questions about Retension Pharmaceuticals, Inc. Common Stock

What is the Retension Pharmaceuticals, Inc. Common Stock stock price today?

The current price of Retension Pharmaceuticals, Inc. Common Stock (RTSN) is 10.51. Over the past 24 hours, the stock has changed by -19.22%. Follow the RTSN chart for real-time price dynamics.

What is the stock ticker of Retension Pharmaceuticals, Inc. Common Stock?

Retension Pharmaceuticals, Inc. Common Stock trades under the ticker RTSN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Retension Pharmaceuticals, Inc. Common Stock stock going up?

RTSN has changed by -13.78% over the last week, -29.03% over the last month, and +5.10% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Retension Pharmaceuticals, Inc. Common Stock?

Retension Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 93.48 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Retension Pharmaceuticals, Inc. Common Stock earnings last quarter?

Last quarter, Retension Pharmaceuticals, Inc. Common Stock reported earnings of -7.33 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Retension Pharmaceuticals, Inc. Common Stock revenue for the last quarter?

Retension Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

How many employees does Retension Pharmaceuticals, Inc. Common Stock have?

As of the latest available data, Retension Pharmaceuticals, Inc. Common Stock has 12 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Retension Pharmaceuticals, Inc. Common Stock stock?

You can buy Retension Pharmaceuticals, Inc. Common Stock (RTSN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Retension Pharmaceuticals, Inc. Common Stock stock?

Investing in Retension Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RTSN chart and related analysis on metatrader.com as part of your research.